Orin
AXTANYSE·Chemicals - Specialty

Axalta Coating Systems Ltd.

Market cap $7.4BP/E 21.2× trailingGross margin 32.6%
$34.52
+0.35 (+1.02%)Tue 27 Oct close 16:00 ET
52-wk $24.94 – $38.61
Orin's take
6out of 10 — how sure Orin is of this read

Orin's own judgment of how firmly the evidence points one way — not the chance the price goes up.

Refreshed 24 Sep, the 5th take on AXTA. A new filing or a print queues the next refresh.

Axalta's fundamentals are improving — Q2 2026 revenue grew 3.1% YoY (first positive growth in five quarters), operating margin expanded to 14.9% for full-year 2025 from 13.4% in 2024, and the company has beaten EPS estimates by double digits in two of the last three reported quarters — yet the stock has fallen from roughly $37 to $32.43, trading below its 50-day MA of $35.03 and nearing its 200-day MA of $32.07 with an RSI of 36.3.

The pending AkzoNobel merger with $600M in targeted synergies represents the dominant value catalyst, but the fixed exchange ratio means AXTA shareholders' ultimate value depends on deal completion and AkzoNobel's share price, creating binary outcome risk. With valuation mixed (19.9 PE vs 17.3 peer median, but 1.35 PS vs 2.35 peer median) and technicals deteriorating, patience is warranted until either the deal closes or the stock stabilizes at support.

What could go wrong

  • Merger execution risk. The all-stock AkzoNobel merger with $600M targeted synergies hinges on regulatory approval and integration; a breakup or delay would remove the primary catalyst and likely reset the shares lower.
  • Revenue softness persists. Full-year 2025 revenue declined 3.0% to $5.12B from $5.28B in 2024; while Q2 2026 showed 3.1% YoY growth, sustained volume recovery remains unconfirmed and headline growth is aided by price/mix and acquisitions.
  • Technical breakdown. Stock at $32.43 is below its 50-day MA of $35.03 and barely above its 200-day MA of $32.07, with MACD histogram at -0.26 and RSI at 36.3; a breach of the 200-day could trigger further selling.
  • Insider net selling. Over the trailing 24 months, insiders have net sold $10.5M in value across 301 transactions, with 170 dispositions vs 131 acquisitions, though recent activity is primarily RSU vesting and tax withholding rather than open-market selling.

What would change my mind

Merger completion. AkzoNobel deal receives all regulatory approvals and closes, unlocking $600M synergy target and converting AXTA shares into AkzoNobel shares at the fixed exchange ratiobullish
Deal breakup or delay. Regulatory rejection, extended review, or either party terminating the merger agreementbearish
Revenue growth acceleration. Two consecutive quarters of organic revenue growth above 3% YoY with volume-driven contribution rather than price/mix alonebullish
200-day MA breach. Stock closes below $32.07 (200-day MA) on sustained volume, signaling loss of long-term technical supportbearish

Where this comes from: Q2 2026 results · FY24 and FY25 fundamentals · earnings vs estimates, 28 Jul · technicals, 23 Sep. Orin's read on AXTA; not advice.

How has the share price moved?

27 Oct 2025 – 27 Oct 2026

Up 18.8% over twelve months, from $29.06 on 27 Oct 2025 to $34.52 at the Tue 27 Oct 2026 close. Its highest close in that time was $38.19 on 7 Aug 2026; the last close is 9.6% below it.

Jan 2026AprJulOct
    • Green line: the closing price each trading day.
    • Grey line: the average closing price over the last 50 trading days.
    • Dashed amber line: the same over the last 200 trading days — a slower, smoother line.
    • Bars along the bottom: shares traded each day — green when it closed higher than the day before, rose when lower (the most, 18.7M, on 18 Nov 2025).
    • Flags: the company's filings, on the day they were made (a 10-Q is the quarterly report and a 10-K the annual report; an 8-K reports a major event).

    Largest holders · 13F Q2 2026

    Money flow
    FilerPositionOf fund
    BlackRock$668.5M0.0%
    Vanguard Capital Management$332.0M0.0%
    Vanguard Portfolio Management$325.8M0.0%
    State Street$228.9M0.0%
    D. E. Shaw$224.0M0.1%
    FMR$207.4M0.0%
    Millennium Management$187.1M0.1%
    Massachusetts Financial Services$187.0M0.1%
    Geode Capital Management$139.7M0.0%
    Sessa Capital IM$121.1M2.0%

    66 of the 815 filers we track · quarter ended Q2 2026 · positions, not flows

    Insiders, last 24 months: 293 Form 4 filings; open-market trades net −$492K. Of the 50 on hand, none was an open-market trade — the rest are grants, option exercises and tax withholding.

    Ask Orin about AXTA

    its filings · its transcripts · its numbers

    Orin answers questions about AXTA from its filings, transcripts and numbers — with the source behind every claim. Your own desk starts with 3 free days, card required.

    Start 3 free days →

    How is it priced, against its own past and its sector?

    Tue 27 Oct close

    Priced at 21.2× its last 12 months of profit (Tue 27 Oct close) — higher than in 2 of its last 5 fiscal years (middle 28.1×); the typical Basic Materials company on the NYSE is at 22.4×.

    MeasureNowIts usualSector
    P/E21.2×below usual28.1×22.4×
    P/S1.43×near usual1.42×—
    EV/EBITDA10.0×below usual12.3×—
    P/B2.9×below usual3.9×—
    • "Its usual" is the middle of its own last 5 fiscal years.

    P/E: the share price divided by one year of profit per share — roughly how many years of today's profit the price pays for. A company that loses money has no P/E.

    P/S: the company's total market value divided by one year of revenue. Used when there is no profit to measure.

    EV/EBITDA: the price of the whole company (its shares plus its debt, minus its cash) divided by one year of operating profit before interest, tax and write-downs.

    P/B: the share price divided by the book value per share — what the company owns minus what it owes, as its accounts record it. When book value is tiny, P/B swings wildly and says little.

    What do the analysts who cover it publish?

    13 firms rated it in the last 18 months · 27 Oct

    The analysts' average 12-month price target is $39.50 (from $32 to $47) — 14% above the Tue 27 Oct close price. That is their published opinion, not Orin's.

    Average price target

    $39.50

    $32 – $47 · +14% against the last close

    Their ratings
    • 5 buy or overweight
    • 8 hold
    • 0 underweight or sell

    Price target: the share price an analyst publishes for about 12 months ahead. It is the opinion of the firm that wrote it; the average is across the firms that cover the company.

    Overweight / underweight: analysts' rating words: overweight means the firm expects the stock to do better than the others it covers, underweight worse. Their words, not Orin's.

    How is it priced next to the companies it is compared to?

    middle P/E 16.1× · 3 of 3 with a profit

    Priced at 21.2× its last 12 months of profit; the middle P/E of the 3 companies it is compared to that made a profit is 16.1×.

    CompanyMarket valueP/EEV/EBITDAGross marginNet marginROE
    AXTAAxalta Coating Systems Ltd.$7B21.2×10.0×32.6%6.8%15%
    FULH.B. Fuller Company$3B13.6×8.6×32.8%5.6%10%
    PPGPPG Industries, Inc.$25B16.1×12.2×29.5%9.4%n/m
    SHWThe Sherwin-Williams Company$79B29.7×20.2×48.7%10.7%27%
    • PPG: return on equity is not meaningful (n/m) — book value is below zero.
    • The list of companies is the data vendor's choice, so it can include a company a person would not have picked.

    Market value: the share price times the number of shares — what the whole company is priced at.

    P/E: the share price divided by one year of profit per share — roughly how many years of today's profit the price pays for. A company that loses money has no P/E.

    EV/EBITDA: the price of the whole company (its shares plus its debt, minus its cash) divided by one year of operating profit before interest, tax and write-downs.

    Gross margin: the share of each $1 of sales left after the direct cost of making what was sold.

    Net margin: the share of each $1 of sales kept as profit after every cost. Below zero, the company lost money.

    ROE: return on equity: one year of profit as a share of the shareholders' money in the business (its book value).

    Is it priced high or low compared with its own past?

    Tue 27 Oct

    Priced at 21.2× its last 12 months of profit (Tue 27 Oct close). It has no full fiscal year on file since its history starts, so there is nothing of its own to compare with.

    • Now21.2×

    P/E: the share price divided by one year of profit per share — roughly how many years of today's profit the price pays for. A company that loses money has no P/E.

    Fiscal year (FY): the company's own 12-month accounting year, which need not match the calendar year.

    How has its sector been priced?

    Now–Now · Tue 27 Oct

    Basic Materials companies on the NYSE were priced at a typical 22.4× their yearly profit (Tue 27 Oct close).

    • Now22.4×
    • Each year is the middle of that calendar year's daily sector P/E; "Now" is the Tue 27 Oct close figure, the same one in the table above.

    Sector P/E: the middle P/E of the companies in the same sector on the same stock exchange, as the data vendor works it out each day.

    What does a cash-flow model say a share is worth?

    computed 27 Oct at $34.41

    A standard cash-flow model puts it at $53 a share — 54% above the $34.41 price it was computed against (27 Oct).

    ModelValue a shareAgainst the price then
    Standard$5354% above $34.41
    Levered$326% below $34.41

    Discounted cash flow: a model's estimate of what the company is worth today, from the cash it is forecast to make in future years. Small changes in the forecast move it a lot, and it says little about a company that loses money.

    Standard / levered: two versions of the cash-flow model: the standard one counts the cash before the company pays its lenders, the levered one after.